Huaidong Hu

1.1k total citations
29 papers, 864 citations indexed

About

Huaidong Hu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Huaidong Hu has authored 29 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Huaidong Hu's work include Cancer, Lipids, and Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Huaidong Hu is often cited by papers focused on Cancer, Lipids, and Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Huaidong Hu collaborates with scholars based in China, United States and United Kingdom. Huaidong Hu's co-authors include Hong Ren, Yixuan Yang, Peng Hu, Shasha Shen, Jiaojiao Gong, Si Qin, Juan Huang, Sanglin Li, Rong Xiang and Dazhi Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Huaidong Hu

28 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huaidong Hu China 17 418 201 183 136 125 29 864
Zhiming Liu China 19 490 1.2× 183 0.9× 135 0.7× 175 1.3× 100 0.8× 50 923
Changguo Chen China 19 768 1.8× 273 1.4× 386 2.1× 165 1.2× 131 1.0× 35 1.3k
Sreedevi Avasarala United States 14 632 1.5× 185 0.9× 176 1.0× 78 0.6× 53 0.4× 19 967
Hong Yi China 20 489 1.2× 172 0.9× 119 0.7× 73 0.5× 104 0.8× 63 893
Ramachandran Rashmi United States 15 717 1.7× 169 0.8× 136 0.7× 96 0.7× 129 1.0× 18 1.0k
Shilpa Kuttikrishnan Qatar 21 781 1.9× 240 1.2× 257 1.4× 111 0.8× 80 0.6× 46 1.2k
C. Richard Boland United States 12 615 1.5× 318 1.6× 165 0.9× 68 0.5× 101 0.8× 28 1.1k
Jean‐Pierre Couty France 16 417 1.0× 108 0.5× 248 1.4× 204 1.5× 296 2.4× 29 1.1k
Ángeles Carlos‐Reyes Mexico 13 549 1.3× 254 1.3× 200 1.1× 95 0.7× 50 0.4× 31 908
Praveenkumar Shetty India 18 496 1.2× 181 0.9× 122 0.7× 136 1.0× 54 0.4× 58 847

Countries citing papers authored by Huaidong Hu

Since Specialization
Citations

This map shows the geographic impact of Huaidong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaidong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaidong Hu more than expected).

Fields of papers citing papers by Huaidong Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaidong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaidong Hu. The network helps show where Huaidong Hu may publish in the future.

Co-authorship network of co-authors of Huaidong Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Huaidong Hu. A scholar is included among the top collaborators of Huaidong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaidong Hu. Huaidong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Tingting, et al.. (2022). Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinoma. Scientific Reports. 12(1). 15347–15347. 2 indexed citations
2.
Hu, Huaidong, et al.. (2021). [Retracted] MicroRNA‑138 inhibits migration and invasion of non‑small cell lung cancer cells by targeting LIMK1. Molecular Medicine Reports. 24(2). 1 indexed citations
3.
Huang, Juan, Yaoliang Tang, Yi Lü, et al.. (2020). Identification of the fatty acid synthase interaction network via iTRAQ-based proteomics indicates the potential molecular mechanisms of liver cancer metastasis. Cancer Cell International. 20(1). 332–332. 11 indexed citations
4.
Zhang, Wenyue, Juan Huang, Yaoliang Tang, Yixuan Yang, & Huaidong Hu. (2020). Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway. Annals of Hepatology. 19(4). 411–416. 21 indexed citations
5.
6.
7.
Gong, Jiaojiao, Shasha Shen, Yixuan Yang, et al.. (2017). Inhibition of FASN suppresses migration, invasion and growth in hepatoma carcinoma cells by deregulating the HIF-1α/IGFBP1 pathway. International Journal of Oncology. 50(3). 883–892. 30 indexed citations
8.
Shen, Shasha, Jiaojiao Gong, Yixuan Yang, et al.. (2017). Molecular mechanism of C-reaction protein in promoting migration and invasion of hepatocellular carcinoma cells in vitro. International Journal of Oncology. 50(4). 1289–1298. 10 indexed citations
9.
Liu, Yi, Yixuan Yang, Huaidong Hu, et al.. (2015). A secretomic study on human hepatocellular carcinoma multiple drug-resistant cell lines. Oncology Reports. 34(3). 1249–1260. 10 indexed citations
10.
11.
Hu, Huaidong, Yixuan Yang, Hongmin Zhang, et al.. (2014). Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 307(6). G611–G622. 36 indexed citations
12.
Tong, Shiwen, Yixuan Yang, Huaidong Hu, et al.. (2012). HSPB1 is an intracellular antiviral factor against hepatitis B virus. Journal of Cellular Biochemistry. 114(1). 162–173. 27 indexed citations
13.
Wang, Lina, Si Chen, Mingna Zhang, et al.. (2012). Legumain: A biomarker for diagnosis and prognosis of human ovarian cancer. Journal of Cellular Biochemistry. 113(8). 2679–2686. 91 indexed citations
14.
Tong, Shiwen, Yixuan Yang, Huaidong Hu, et al.. (2011). Proteomic investigation of 5‐fluorouracil resistance in a human hepatocellular carcinoma cell line. Journal of Cellular Biochemistry. 113(5). 1671–1680. 42 indexed citations
15.
Hu, Huaidong, Feng Ye, Dazhi Zhang, et al.. (2010). iTRAQ Quantitative Analysis of Multidrug Resistance Mechanisms in Human Gastric Cancer Cells. SHILAP Revista de lepidopterología. 2010. 1–11. 25 indexed citations
16.
Li, Sanglin, Feng Ye, Wei‐Jun Cai, et al.. (2010). Quantitative proteome analysis of multidrug resistance in human ovarian cancer cell line. Journal of Cellular Biochemistry. 109(4). 625–633. 44 indexed citations
17.
Hu, Peng, Huaidong Hu, Min Chen, et al.. (2009). Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma. Molecular Immunology. 46(8-9). 1654–1662. 43 indexed citations
18.
Hu, Peng, Min Chen, Huaidong Hu, et al.. (2009). Molecular cloning, expression and characterization of an interleukin 27 p28 homolog in pig (Sus scrofa). Veterinary Immunology and Immunopathology. 130(3-4). 262–267.
19.
Yang, Yixuan, Xuefeng Sun, Ailan Cheng, et al.. (2008). Increased expression of HSP27 linked to vincristine resistance in human gastric cancer cell line. Journal of Cancer Research and Clinical Oncology. 135(2). 181–189. 25 indexed citations
20.
Lewén, Susanna, He Zhou, Huaidong Hu, et al.. (2007). A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis. Cancer Immunology Immunotherapy. 57(4). 507–515. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiming Liu Breakdown of academic impact, for papers by Changguo Chen Breakdown of academic impact, for papers by Sreedevi Avasarala Breakdown of academic impact, for papers by Hong Yi Breakdown of academic impact, for papers by Ramachandran Rashmi Breakdown of academic impact, for papers by Shilpa Kuttikrishnan Breakdown of academic impact, for papers by C. Richard Boland Breakdown of academic impact, for papers by Jean‐Pierre Couty Breakdown of academic impact, for papers by Ángeles Carlos‐Reyes Breakdown of academic impact, for papers by Praveenkumar Shetty
Rankless by CCL
2026